Clinical trial
Understanding of the Patient and Caregiver Experience of Wiskott-Aldrich Syndrome (WAS)
NCT03399461 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding of the Patient and Caregiver Experience of Wiskott-Aldrich Syndrome (WAS)
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 24, 2018
- Completion date
- September 14, 2018
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.